Logo image of BN

BROOKFIELD CORP (BN) Stock Fundamental Analysis

NYSE:BN - New York Stock Exchange, Inc. - CA11271J1075 - Common Stock - Currency: USD

63.16  -0.8 (-1.25%)

After market: 63.13 -0.03 (-0.05%)

Fundamental Rating

3

BN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 233 industry peers in the Capital Markets industry. BN may be in some trouble as it scores bad on both profitability and health. BN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

BN had positive earnings in the past year.
BN had a positive operating cash flow in the past year.
BN had positive earnings in 4 of the past 5 years.
BN had a positive operating cash flow in each of the past 5 years.
BN Yearly Net Income VS EBIT VS OCF VS FCFBN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B

1.2 Ratios

BN has a worse Return On Assets (0.09%) than 72.96% of its industry peers.
BN has a Return On Equity of 0.99%. This is in the lower half of the industry: BN underperforms 70.39% of its industry peers.
With a Return On Invested Capital value of 3.48%, BN perfoms like the industry average, outperforming 43.35% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BN is below the industry average of 7.86%.
Industry RankSector Rank
ROA 0.09%
ROE 0.99%
ROIC 3.48%
ROA(3y)0.24%
ROA(5y)0.32%
ROE(3y)2.5%
ROE(5y)2.99%
ROIC(3y)3.69%
ROIC(5y)3.45%
BN Yearly ROA, ROE, ROICBN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

Looking at the Profit Margin, with a value of 0.55%, BN is doing worse than 71.67% of the companies in the same industry.
BN's Profit Margin has declined in the last couple of years.
BN has a Operating Margin of 24.95%. This is comparable to the rest of the industry: BN outperforms 46.35% of its industry peers.
BN's Operating Margin has improved in the last couple of years.
The Gross Margin of BN (35.04%) is worse than 69.96% of its industry peers.
BN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 24.95%
PM (TTM) 0.55%
GM 35.04%
OM growth 3Y4.81%
OM growth 5Y5.87%
PM growth 3Y-52.22%
PM growth 5Y-32.46%
GM growth 3Y8.55%
GM growth 5Y6.54%
BN Yearly Profit, Operating, Gross MarginsBN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

2

2. Health

2.1 Basic Checks

The number of shares outstanding for BN has been reduced compared to 1 year ago.
The number of shares outstanding for BN remains at a similar level compared to 5 years ago.
BN has a worse debt/assets ratio than last year.
BN Yearly Shares OutstandingBN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
BN Yearly Total Debt VS Total AssetsBN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B

2.2 Solvency

BN has a Debt/Equity ratio of 5.43. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 5.43, BN is doing worse than 85.41% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 5.43
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
BN Yearly LT Debt VS Equity VS FCFBN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50B 100B 150B

2.3 Liquidity

BN has a Current Ratio of 1.11. This is a normal value and indicates that BN is financially healthy and should not expect problems in meeting its short term obligations.
BN has a Current ratio (1.11) which is comparable to the rest of the industry.
BN has a Quick Ratio of 1.11. This is a bad value and indicates that BN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.96, BN is in line with its industry, outperforming 44.21% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.96
BN Yearly Current Assets VS Current LiabilitesBN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

6

3. Growth

3.1 Past

BN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.71%, which is quite impressive.
Measured over the past years, BN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.12% on average per year.
Looking at the last year, BN shows a very negative growth in Revenue. The Revenue has decreased by -15.17% in the last year.
The Revenue has been growing slightly by 4.86% on average over the past years.
EPS 1Y (TTM)35.71%
EPS 3Y-49.52%
EPS 5Y18.12%
EPS Q2Q%27.27%
Revenue 1Y (TTM)-15.17%
Revenue growth 3Y4.33%
Revenue growth 5Y4.86%
Sales Q2Q%1284.57%

3.2 Future

Based on estimates for the next years, BN will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.32% on average per year.
The Revenue is expected to grow by 20.22% on average over the next years. This is a very strong growth
EPS Next Y-0.27%
EPS Next 2Y9.25%
EPS Next 3Y11.32%
EPS Next 5YN/A
Revenue Next Year28.06%
Revenue Next 2Y20.03%
Revenue Next 3Y20.22%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BN Yearly Revenue VS EstimatesBN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B 80B
BN Yearly EPS VS EstimatesBN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3 4 5

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 15.11, the valuation of BN can be described as correct.
BN's Price/Earnings ratio is in line with the industry average.
BN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.41.
Based on the Price/Forward Earnings ratio of 13.33, the valuation of BN can be described as correct.
BN's Price/Forward Earnings is on the same level as the industry average.
BN is valuated cheaply when we compare the Price/Forward Earnings ratio to 35.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.11
Fwd PE 13.33
BN Price Earnings VS Forward Price EarningsBN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BN is valued cheaper than 86.70% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.27
BN Per share dataBN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.83
EPS Next 2Y9.25%
EPS Next 3Y11.32%

4

5. Dividend

5.1 Amount

BN has a Yearly Dividend Yield of 5.94%, which is a nice return.
BN's Dividend Yield is comparable with the industry average which is at 7.77.
Compared to an average S&P500 Dividend Yield of 2.35, BN pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.94%

5.2 History

The dividend of BN decreases each year by -3.57%.
BN has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of BN decreased recently.
Dividend Growth(5Y)-3.57%
Div Incr Years1
Div Non Decr Years1
BN Yearly Dividends per shareBN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

BN pays out 151.35% of its income as dividend. This is not a sustainable payout ratio.
DP151.35%
EPS Next 2Y9.25%
EPS Next 3Y11.32%
BN Yearly Income VS Free CF VS DividendBN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5B -10B
BN Dividend Payout.BN Dividend Payout, showing the Payout Ratio.BN Dividend Payout.PayoutRetained Earnings

BROOKFIELD CORP

NYSE:BN (7/11/2025, 8:04:01 PM)

After market: 63.13 -0.03 (-0.05%)

63.16

-0.8 (-1.25%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners56.19%
Inst Owner Change0%
Ins Owners10.27%
Ins Owner ChangeN/A
Market Cap104.09B
Analysts76.67
Price Target68.34 (8.2%)
Short Float %1.25%
Short Ratio8.05
Dividend
Industry RankSector Rank
Dividend Yield 5.94%
Yearly Dividend0.44
Dividend Growth(5Y)-3.57%
DP151.35%
Div Incr Years1
Div Non Decr Years1
Ex-Date06-13 2025-06-13 (0.09)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.97%
Min EPS beat(2)6.19%
Max EPS beat(2)11.75%
EPS beat(4)3
Avg EPS beat(4)21.57%
Min EPS beat(4)-0.3%
Max EPS beat(4)68.65%
EPS beat(8)7
Avg EPS beat(8)14.69%
EPS beat(12)9
Avg EPS beat(12)-3.55%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1228.35%
Min Revenue beat(2)1136.66%
Max Revenue beat(2)1320.03%
Revenue beat(4)4
Avg Revenue beat(4)1410.47%
Min Revenue beat(4)1136.66%
Max Revenue beat(4)1712.11%
Revenue beat(8)8
Avg Revenue beat(8)707.05%
Revenue beat(12)12
Avg Revenue beat(12)490.56%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.08%
PT rev (3m)-1.68%
EPS NQ rev (1m)-0.18%
EPS NQ rev (3m)-3.72%
EPS NY rev (1m)-0.1%
EPS NY rev (3m)-0.47%
Revenue NQ rev (1m)3.27%
Revenue NQ rev (3m)1.16%
Revenue NY rev (1m)0.86%
Revenue NY rev (3m)2.94%
Valuation
Industry RankSector Rank
PE 15.11
Fwd PE 13.33
P/S 1.28
P/FCF N/A
P/OCF 11.88
P/B 2.3
P/tB N/A
EV/EBITDA 11.27
EPS(TTM)4.18
EY6.62%
EPS(NY)4.74
Fwd EY7.5%
FCF(TTM)-8.64
FCFYN/A
OCF(TTM)5.32
OCFY8.42%
SpS49.17
BVpS27.46
TBVpS-17.58
PEG (NY)N/A
PEG (5Y)0.83
Profitability
Industry RankSector Rank
ROA 0.09%
ROE 0.99%
ROCE 4.67%
ROIC 3.48%
ROICexc 3.58%
ROICexgc 4.35%
OM 24.95%
PM (TTM) 0.55%
GM 35.04%
FCFM N/A
ROA(3y)0.24%
ROA(5y)0.32%
ROE(3y)2.5%
ROE(5y)2.99%
ROIC(3y)3.69%
ROIC(5y)3.45%
ROICexc(3y)3.83%
ROICexc(5y)3.59%
ROICexgc(3y)4.77%
ROICexgc(5y)4.39%
ROCE(3y)4.96%
ROCE(5y)4.64%
ROICexcg growth 3Y2.5%
ROICexcg growth 5Y4.8%
ROICexc growth 3Y1.58%
ROICexc growth 5Y3.93%
OM growth 3Y4.81%
OM growth 5Y5.87%
PM growth 3Y-52.22%
PM growth 5Y-32.46%
GM growth 3Y8.55%
GM growth 5Y6.54%
F-Score6
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 5.43
Debt/FCF N/A
Debt/EBITDA 8.21
Cap/Depr 236.74%
Cap/Sales 28.38%
Interest Coverage 250
Cash Conversion 29.26%
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 0.96
Altman-Z N/A
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)209.51%
Cap/Depr(5y)213.66%
Cap/Sales(3y)20.38%
Cap/Sales(5y)19.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.71%
EPS 3Y-49.52%
EPS 5Y18.12%
EPS Q2Q%27.27%
EPS Next Y-0.27%
EPS Next 2Y9.25%
EPS Next 3Y11.32%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.17%
Revenue growth 3Y4.33%
Revenue growth 5Y4.86%
Sales Q2Q%1284.57%
Revenue Next Year28.06%
Revenue Next 2Y20.03%
Revenue Next 3Y20.22%
Revenue Next 5YN/A
EBIT growth 1Y-4.56%
EBIT growth 3Y9.35%
EBIT growth 5Y11.02%
EBIT Next Year486.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-69.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8.13%
OCF growth 3Y-1.38%
OCF growth 5Y3.07%